Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 104.1B | 12.3B | 18.9B | 41.5B |
Cost of revenue | 75.9B | 8.9B | 13.8B | 31.7B |
Gross profit | 28.1B | 3.4B | 5.2B | 9.9B |
Operating expense | ||||
Research & development | 609.5M | 648.8M | — | — |
Selling general and admin | 2.7B | 3.6B | 9.2B | 7.5B |
Other operating expenses | 1.2B | -3.0B | — | — |
Operating income | 19.2B | -3.9B | -4.0B | 2.3B |
Non operating interest income | ||||
Income | 227.5M | 84.1M | — | — |
Expense | 79.1M | 343.2M | — | — |
Other income expense | — | — | — | — |
Pretax income | 19.8B | -6.5B | -2.9B | 1.7B |
Tax provision | 4.6B | -1.9B | -647.0M | 334.6M |
Net income | 15.2B | -4.6B | -2.3B | 1.4B |
Basic EPS | 1.2K | — | -183 | 107 |
Diluted EPS | 1.2K | — | -183 | 107 |
Basic average shares | 12.4M | — | 12.4M | 12.4M |
Diluted average shares | 12.4M | — | 12.4M | 12.4M |
EBITDA | 20.6B | -6.1B | -3.0B | 3.4B |
Net income from continuing op. | 15.2B | -4.6B | -2.3B | 1.4B |
Minority interests | -7.6M | 17.3M | -7.1M | -60.1M |
Preferred stock dividends | — | — | — | — |